poster
Presented at: ASCO 2019
A phase I clinical trial on intratumoral administration of autologous CD1c (BDCA-1)+ myeloid dendritic cells (myDC) plus talimogene laherparepvec (T-VEC) in patients with advanced melanoma
Register here for download
Relevant for
FixVUE, InSituPlex
Presented at SITC 2019.
Authors
Schwarze JK., Awada G., Cras L., Forsyth R., Dufait I., Van Reit I. and Neyns B.
Want to meet with us? Check out our upcoming events.
Related Content
Learn more
poster
Characterizing spatial distribution of immune-cell subsets in Nonalcoholic Steatohepatitis and Primary Sclerosing Cholangitis using a novel 12-plex Ultimapper ® kit
Presented at EASL 2021
Learn more
ebook
Overview of the differences between standard IHC and multiplexed immunofluoresence
Ultivue
Learn more
webinar
Combinatorial Immunotherapy Approaches for Patients with Advanced Solid Tumors
Length: 60 minutes
